These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 18084362)

  • 41. [Current views on the pathogenesis and therapy of ankylosing spondylitis].
    Biasi D; Carletto A; Caramaschi P; Zeminian S; Bezzi D; Baracchino F; Bambara ML
    Clin Ter; 1993 Dec; 143(6):511-8. PubMed ID: 8306575
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pharmacotherapy (excluding biotherapies) for ankylosing spondylitis: development of recommendations for clinical practice based on published evidence and expert opinion.
    Lavie F; Pavy S; Dernis E; Goupille P; Cantagrel A; Tebib J; Claudepierre P; Flipo RM; Le Loët X; Maillefert JF; Mariette X; Saraux A; Schaeverbeke T; Wendling D; Combe B
    Joint Bone Spine; 2007 Jul; 74(4):346-52. PubMed ID: 17590370
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Treatment of ankylosing and non-ankylosing spondylitis.
    Donnelly P
    Ir Med J; 1993; 86(6):175-6. PubMed ID: 8106217
    [No Abstract]   [Full Text] [Related]  

  • 44. [Recommendations for the management of ankylosing spodylitis after ASAS/EULAR. Evaluation in the German language area].
    Braun J; Zochling J; Märker-Hermann E; Stucki G; Böhm H; Rudwaleit M; Zeidler H; Sieper J
    Z Rheumatol; 2006 Dec; 65(8):728-42. PubMed ID: 17119900
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Reactive arthritis].
    Chaabouni L; Ben Hamouda S; Abdelmoula L; Ben Hadj Yahia C; Kchir MM; Zouari R
    Tunis Med; 2004 Dec; 82(12):1064-9. PubMed ID: 15822506
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Etoricoxib: new drug. Avoid using cox-2 inhibitors for pain.
    Prescrire Int; 2007 Dec; 16(92):223-7. PubMed ID: 18084859
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Treatment of ankylosing spondylitis: a critical appraisal of nonsteroidal anti-inflammatory drugs and corticosteroids.
    Khan MA; Garcia-Kutzbach A; Espinoza LR
    Am J Med Sci; 2012 May; 343(5):350-2. PubMed ID: 22543535
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Ankylosing spondylitis: an update.
    Golder V; Schachna L
    Aust Fam Physician; 2013 Nov; 42(11):780-4. PubMed ID: 24217097
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Danish recommendations on treatment of ankylosing spondylitis and spondyloarthritis based on multinational project initiative].
    Pedersen SJ; Madsen OR; Erlendsson J; Schiøttz-Christensen B; Sørensen IJ; Andersen LS; Ostergaard M
    Ugeskr Laeger; 2008 Dec; 170(49):4044-50. PubMed ID: 19087747
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Proposal for levels of evidence schema for validation of a soluble biomarker reflecting damage endpoints in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis, and recommendations for study design.
    Maksymowych WP; Fitzgerald O; Wells GA; Gladman DD; Landewé R; Ostergaard M; Taylor WJ; Christensen R; Tak PP; Boers M; Syversen SW; Bathon JM; Ritchlin CJ; Mease PJ; Bykerk VP; Garnero P; Geusens P; El-Gabalawy H; Aletaha D; Inman RD; Kraus VB; Kvien TK; van der Heijde D
    J Rheumatol; 2009 Aug; 36(8):1792-9. PubMed ID: 19671814
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Trend towards increased arterial stiffness or intima-media thickness in ankylosing spondylitis patients without clinically evident cardiovascular disease.
    Mathieu S; Joly H; Baron G; Tournadre A; Dubost JJ; Ristori JM; Lusson JR; Soubrier M
    Rheumatology (Oxford); 2008 Aug; 47(8):1203-7. PubMed ID: 18524805
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Can structural damage be prevented in ankylosing spondylitis?
    Sieper J
    Curr Opin Rheumatol; 2009 Jul; 21(4):335-9. PubMed ID: 19424070
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Therapy of the spondyloarthropathies.
    Smythe H
    Clin Orthop Relat Res; 1979 Sep; (143):84-9. PubMed ID: 116795
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Ankylosing spondylitis].
    Komatsubara Y
    Ryumachi; 1995 Jun; 35(3):503-4. PubMed ID: 7570202
    [No Abstract]   [Full Text] [Related]  

  • 55. [Treatment of ankylosing spondylarthritis. A new therapeutic alternative].
    Duró JC
    Med Clin (Barc); 1983 Jan; 80(2):83-4. PubMed ID: 6843213
    [No Abstract]   [Full Text] [Related]  

  • 56. [Early diagnosis of ankylosing spondylitis].
    Pavelka K
    Vnitr Lek; 2006; 52(7-8):726-9. PubMed ID: 16967615
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Contemporary management of ankylosing spondylitis.
    Calabro JJ; Eyvazzadeh C; Weber CA
    Compr Ther; 1986 Sep; 12(9):11-8. PubMed ID: 3533404
    [TBL] [Abstract][Full Text] [Related]  

  • 58. NSAIDs in ankylosing spondylitis.
    Miceli-Richard C; Dougados M
    Clin Exp Rheumatol; 2002; 20(6 Suppl 28):S65-6. PubMed ID: 12463450
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Enthesitis in connection with spondyloarthritides].
    Haibel H; Sieper J
    Orthopade; 2015 May; 44(5):395-404; quiz 405-6. PubMed ID: 25920504
    [TBL] [Abstract][Full Text] [Related]  

  • 60. First update of the current evidence for the management of ankylosing spondylitis with non-pharmacological treatment and non-biologic drugs: a systematic literature review for the ASAS/EULAR management recommendations in ankylosing spondylitis.
    van den Berg R; Baraliakos X; Braun J; van der Heijde D
    Rheumatology (Oxford); 2012 Aug; 51(8):1388-96. PubMed ID: 22513148
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.